Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
4′-Methoxy-N,N-dimethyl-3′-[[[3-[[2-[(3-(dimethylcarbamoyl)benzoyl)amino]ethyl]amino]phenyl]amino]sulfonyl]-[1,1′-biphenyl]-3-carboxamide is a sulfonamide derivative which was reported to show orexin 2 receptor agonist activity, and thus useful for the treatment of obesity, diabetes, and depression.